Management of atopic dermatitis

NBUVB: narrowband ultraviolet B; TCI: topical calcineurin inhibitor; TCS: topical corticosteroid.

• Irritants (soaps, detergents)
• Skin infections (Staphylococcus aureus, herpes simplex)
• Contact, inhalant, or food allergens

¶ Mild atopic dermatitis – Areas of dry skin, infrequent itching (with or without small areas of redness); little impact on everyday activities, sleep, and psychosocial wellbeing.

Δ Moderate atopic dermatitis – Areas of dry skin, frequent itching, redness (with or without excoriation and localized skin thickening); moderate impact on everyday activities and psychosocial wellbeing, frequently disturbed sleep.

◊ Severe atopic dermatitis – Widespread areas of dry skin, incessant itching, redness (with or without excoriation, extensive skin thickening, bleeding, oozing, cracking, and alteration of pigmentation); severe limitation of everyday activities and psychosocial functioning, nightly loss of sleep.

§ Crisaborole is approved for mild to moderate atopic dermatitis in adults and children >3 months.